Dr. Langer is Professor of Medicine in the Hematology/Oncology Division at the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA, where he serves as Director of Thoracic Oncology in the Abramson Cancer Center. Dr Langer received his Medical Degree from Boston University in Boston, MA and completed his internship and residency in Medicine at the Graduate Hospital of the University of Pennsylvania in Philadelphia, PA. Additional postgraduate training included a fellowship in Hematology/Oncology at the Penn Presbyterian Medical Center in amd a fellowship in Oncology at AOH/Fox Chase Cancer Center (FCCC), both in Philadelphia, PA. He is Board Certified in Internal Medicine and in Hematology/Oncology.
Dr Langer served in the oncology division of FCCC for 22 years from 1986 until 2008, and for the last 14 years of his tenure at FCCC, he led its Thoracic Oncology Program. He also served as the research chair of Oncology Physicians Network, a consortium of academic and community facilities in the Delaware Valley allied with FCCC. In June of 2008, he moved to the University of Pennsylvania where he currently leads the Interdisciplinary Thoracic Oncology Program (I-TOP).
Dr Langer is a Fellow of the American College of Physicians and is a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), the International Association for the Study of Lung Cancer (IASLC), and the Society of Head and Neck Surgeons. He has served as Vice-Chair of the Radiation Therapy Oncology Group (RTOG, now NRG) and chairs its Medical Oncology Subcommittee. He also serves on the core Thoracic and Head and Neck Committees of both the Eastern Cooperative Oncology Group (ECOG) and RTOG (NRG).
Dr Langer has contributed numerous articles (>200) and abstracts (>250) to the medical literature. His work on head and neck squamous cell cancer and non-small cell lung cancer has appeared in the New England Journal of Medicine, Seminars in Oncology, Clinical Cancer Research, Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical Lung Cancer, Cancer, Lung Cancer, Cancer Investigation, and EJC. His work has also been presented at the national meetings of ASCO, AACR, ASH, SIOG and the IASLC. He has served three separate terms as a member of the editorial board of the Journal of Clinical Oncology, and is currently on the editorial boards of Clinical Lung Cancer and Clinical Advances in Hematology and Oncology. Dr Langer was also a member of PDQ editorial board/National Cancer Institute protocol submissions and while at FCCC, he served on the NCCN NSCLC and SCLC committees. He reviews articles for the New England Journal of Medicine, Journal of Clinical Oncology, Clinical Lung Cancer, Clinical Cancer Research, Cancer, Annals of Oncology, Lung Cancer, and the Journal of Thoracic Oncology. He is also a frequent lecturer at numerous medical symposia and grand rounds and serves as advisor/commentator for Projects in Knowledge, Impact, CCO, and Medscape.
- Professor of Medicine
University of Pennsylvania